Imac Holdings Inc (BACK)

Sep 10, 2025, 3:04 PM EDT - 6 months ago

Ignite Proteomics Announces Collaboration with Inova Health on a Biomarker Study for Late-Stage Cancers

Aug 7, 2025, 4:05 PM EDT - 7 months ago

IMAC Holdings Announces Research Collaboration with Vanderbilt University Medical Center to Advance Immuno-Oncology Biomarker Discovery

Feb 24, 2025, 8:15 AM EST - 1 year ago

Ignite Proteomics to Present Data on MHC-II as a Predictor of Pembrolizumab Response at NCCN Annual Conference

Feb 19, 2025, 9:15 AM EST - 1 year ago

Ignite Proteomics Completes Acquisition of PLA Code 0249U for Its Advanced Proteomic Breast Cancer Assay

Feb 10, 2025, 9:15 AM EST - 1 year ago

Ignite Proteomics Announces Publication of Study Demonstrating Superiority of Protein Activation Analysis in Predicting Breast Cancer Therapy Response

Jan 27, 2025, 4:10 PM EST - 1 year ago

IMAC Holdings Introduces Ignite Proteomics: A New Standard for Matching Patients with the Right Cancer Therapies

Nov 22, 2024, 5:15 PM EST - 1 year ago

IMAC Holdings receives notification of deficiency from Nasdaq related to delayed filing of quarterly report on Form 10-Q

Nov 14, 2024, 9:10 AM EST - 1 year ago

IMAC Holdings Granted Extension by Nasdaq to Regain Compliance with Listing Rule 5250(c)(1)

Sep 19, 2024, 10:00 AM EDT - 1 year ago

IMAC Holdings Inc. Launches Subsidiary Ignite Proteomics and Announces Groundbreaking Precision Oncology Case Study Utilizing RPPA Technology

Jul 11, 2024, 9:21 AM EDT - 1 year ago

IMAC Holdings, Inc. Appoints Dr. Matthew Schwartz and Dr. Peter Beitsch to Board of Directors

May 24, 2024, 9:00 AM EDT - 1 year ago

IMAC Holdings Announces Leadership Succession

May 7, 2024, 8:30 AM EDT - 2 years ago

IMAC Holdings Acquires Assets of Theralink to Continue Precision Medicine Business

Sep 27, 2023, 4:30 PM EDT - 2 years ago

IMAC Holdings, Inc. Regains Compliance with Nasdaq Listing Requirements

Sep 7, 2023, 12:45 PM EDT - 2 years ago

IMAC Holdings, Inc. Announces 1-for-30 Reverse Stock Split

Jul 26, 2023, 9:25 AM EDT - 2 years ago

IMAC Holdings Announces $4.3 Million Private Placement of Convertible Preferred Stock and Warrants Priced at the Market

Jun 28, 2023, 4:30 PM EDT - 2 years ago

IMAC Holdings Annual Meeting of Shareholders Reminder

May 30, 2023, 11:04 PM EDT - 3 years ago

THERALINK INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Theralink Technologies, Inc. - THER

May 23, 2023, 9:43 AM EDT - 3 years ago

Theralink® Signs Definitive Merger Agreement to be Acquired by IMAC Holdings, a Nasdaq Listed Company

Mar 31, 2023, 8:00 PM EDT - 3 years ago

IMAC Holdings Reports Year End 2022 Financial Results and Corporate Update

Mar 20, 2023, 7:30 AM EDT - 3 years ago

IMAC Holdings and Brain Scientific Announce a Strategic Merger to Create Synergistic End-To-End Neurological Solution

Mar 1, 2023, 9:30 AM EST - 3 years ago

IMAC Holdings, Inc announces the sale of The BackSpace

Oct 21, 2022, 10:30 AM EDT - 3 years ago

IMAC Holdings, Inc. Hosts Hall of Fame Athlete Panel at the Evoke Conference to Launch Whole Food Supplement Partnership

Sep 9, 2022, 9:22 AM EDT - 3 years ago

IMAC Holdings, Inc. Announces Completion of Third Cohort of its Phase 1 Clinical Study of Umbilical Cord-Derived Mesenchymal Stem Cells for the Treatment of Bradykinesia Due to Parkinson's Disease

Sep 7, 2022, 8:30 AM EDT - 3 years ago

Biote Announces Strategic Partnership with IMAC Holdings, Inc.

BTMD

Sep 1, 2022, 9:44 AM EDT - 3 years ago

IMAC Holdings, Inc. Announces Addition of Medical Weight Loss Services to IMAC Regeneration Centers

Aug 16, 2022, 4:00 PM EDT - 3 years ago

IMAC Holdings, Inc. Announces Closing of $3.9 Million Registered Direct and Private Placement Offerings

Aug 15, 2022, 11:30 AM EDT - 3 years ago

IMAC Holdings Reports Record Revenue of $5M in Second Quarter

Aug 12, 2022, 9:16 AM EDT - 3 years ago

IMAC Holdings, Inc. Announces $3.9 Million Registered Direct and Private Placement